Akoustis Technologies, Inc. Stock

Stocks

09-09	Oppenheimer Initiates Coverage on Akoustis Technologies With Outperform Rating, $40 PT	MT
08-19	Aktis Oncology Seen Advancing Targeted Radiation-Based Cancer Drugs, Wedbush Says	MT
08-19	Wedbush Initiates Aktis Oncology at Outperform With $35 Price Target	MT
08-19	BMO Capital Initiates Akoustis Technologies at Outperform	MT
08-13	Earnings Flash (AKTS) Aktis Oncology, Inc. Reports Q2 Revenue $3.4M, vs. FactSet Est of $2.1M	MT
07-10	Aktis Oncology Insider Sold Shares Worth $1,388,701, According to a Recent SEC Filing	MT
07-10	Aktis Oncology Insider Sold Shares Worth $1,387,558, According to a Recent SEC Filing	MT
06-16	Raymond James Initiates Aktis Oncology at Strong Buy With $40 Price Target	MT
05-22	Top Premarket Gainers	MT
05-11	Earnings Flash (AKTS) Aktis Oncology, Inc. Reports Q1 Revenue $3.2M	MT
04-29	William Blair Initiates Aktis Oncology at Outperform	MT
03-30	Aktis Oncology Receives US FDA Approval for AKY-2519 Investigational New Drug Applications	MT
03-09	HC Wainwright Initiates Aktis Oncology at Buy With $30 Price Target	MT

09-09	Oppenheimer Initiates Coverage on Akoustis Technologies With Outperform Rating, $40 PT	MT
08-19	Aktis Oncology Seen Advancing Targeted Radiation-Based Cancer Drugs, Wedbush Says	MT
08-19	Wedbush Initiates Aktis Oncology at Outperform With $35 Price Target	MT
08-19	BMO Capital Initiates Akoustis Technologies at Outperform	MT
06-16	Raymond James Initiates Aktis Oncology at Strong Buy With $40 Price Target	MT

24-12-16	Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process	GL
24-12-16	Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process	BU
24-12-02	Akoustis Technologies : Material Event Form 8 K	PU
24-11-15	Akoustis: Fiscal Q1 Earnings Snapshot	AQ
24-10-28	Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG	AQ

Manager	Title	Age	Since
Robert Dry COO	Chief Operating Officer	-	-
Mary Winters COO	Chief Operating Officer	-	-
Colin Hunt SAM	Sales & Marketing	-	2020-06-01

Director	Title	Age	Since
Jerry Neal CHM	Chairman	82	2016-03-13
Arthur Geiss CHM	Chairman	73	2016-03-13
Jill Frizzley BRD	Director/Board Member	50	2024-08-06

Date	Insider	Type	Main position	Quantity	% Market Cap.
8/8/24	Kamran Cheema	Other	Chief Executive Officer	228,011	0.2089%
1/29/24	David Aichele	Buy	Executive/Senior Manager	80,000	0.1104%
1/29/24	Kenneth Boller	Buy	Chief Financial Officer	60,000	0.0828%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AKOUSTIS TECHNOLOGIES, INC.	-.--%	-.--%	-	-	155
INVESTOR AB	-0.14%	+3.92%	+33.34%	+110.44%	132B
INDUSTRIVÄRDEN AB	-0.57%	+3.47%	+31.35%	+85.11%	22.95B
HAL TRUST	+0.12%	+4.17%	+24.63%	+60.68%	17.12B
MERITZ FINANCIAL GROUP INC.	+1.37%	+1.99%	+18.93%	+168.01%	15.77B
LUNDBERG B	-0.51%	+3.28%	+14.01%	+29.77%	14.72B
INVESTMENT AB LATOUR	+0.05%	+4.19%	-11.39%	+16.23%	14.02B
BAJAJ HOLDINGS & INVESTMENT LIMITED	+0.69%	-9.11%	-19.01%	+51.87%	11.86B
WASHINGTON H. SOUL PATTINSON AND COMPANY LIMITED	+0.39%	-0.44%	+21.99%	+35.01%	12.18B
KINGDOM HOLDING COMPANY	-1.08%	-1.81%	+53.74%	+70.67%	11.78B
Average	+0.05%	+1.53%	+18.62%	+69.75%	28.01B
Weighted average by Cap.	+0.00%	+3.02%	+25.99%	+90.15%